<DOC>
	<DOCNO>NCT03102996</DOCNO>
	<brief_summary>The aim study test alkali treatment preserve kidney graft function diminish progression chronic kidney disease renal transplant patient . Additionally underlying mechanism nephrotoxicity metabolic acidosis investigate cohort . This study multi-center , prospective , randomize , single-blind ( patient ) , placebo-controlled interventional trial test superiority alkali treatment comparison placebo preservation kidney function 300 kidney transplant recipient . The duration study 2 year individual participant . The patient randomize 2 arm : intervention arm ( sodium hydrogen carbonate , product : Nephrotrans® ) placebo arm ( placebo comparator ) . Several study CKD ( chronic kidney disease ) patient show alkali therapy slow progression CKD .</brief_summary>
	<brief_title>Preserve-Transplant Study</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acidosis</mesh_term>
	<criteria>Informed consent document signature age ≥ 18 year able give inform consent ≥ 12 month renal transplantation stable clinical condition stable graft function last 3 month ( creatinine change ± 15 % ) eGFR 1589 ml/min/1.73 m2 serum bicarbonate ≤ 22 mmol/l within last 6 month uncontrolled hypertension use &gt; 4 antihypertensive agent uncontrolled heart failure serum potassium &lt; 3.0 mmol/l serum sodium &gt; 150 mmol/l use alkali precede 3 month use mineralocorticoid antagonist , topiramate , carbo anhydrase inhibitor drug similar effect history noncompliance clinic visit hereditary fructose intolerance know hypersensitivity allergy drug use study peanut , sorbitol , soy pregnancy breastfeed intention become pregnant course study lack safe contraception , define : Female participant childbearing potential , use willing continue use medically reliable method contraception entire study duration , oral , injectable , implantable contraceptive , intrauterine contraceptive device , use method consider sufficiently reliable investigator individual case . please note female participant surgically sterilise / hysterectomised postmenopausal longer 2 year consider child bear potential . suspect drug alcohol abuse inability follow procedure study , e.g . due language problem , psychological disorder , dementia , etc . participant enrolment investigator , his/her family member , employee dependent person</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Alkali</keyword>
	<keyword>Graft</keyword>
	<keyword>Acid base</keyword>
	<keyword>Metabolic acidosis</keyword>
	<keyword>Chronic kidney disease</keyword>
</DOC>